Sumitomo Chemical India Limited (SUMICHEM) — Board Meeting(3 announcements)

The Board approved the audited standalone and consolidated financial results for the year ended March 31, 2026, reporting revenue of **₹31,857.62 crores**, profit before tax of **₹7,266.49 crores**, and exceptional items of **₹151.86 crores** linked to labor code changes. A final dividend of **₹1.30 per share** was declared on 49.91 million equity shares, totaling **₹648.89 crores**, pending shareholder approval at the upcoming AGM. Total assets rose to **₹44,741.91 crores** from ₹39,644.28 crores, and equity increased to **₹33,937.83 crores** from ₹29,050.80 crores, reflecting strong growth. Operating cash flow stood at **₹4,455.14 crores**, though investing activities consumed **₹3,319.53 crores**, leading to a net cash increase of **₹306.82 crores**. The auditor issued an unqualified opinion confirming compliance with Indian Accounting Standards and SEBI regulations, with no material misstatements.

The Board of Sumitomo Chemical India Limited approved the reappointment of Mr. N. Sivaraman as Independent Director for a second term from September 1, 2026 to August 31, 2029, the appointment of Mr. Anand Mohan Tiwari as Independent Director from August 31, 2026 to August 30, 2028, and the appointment of Mr. Chetan Shah as Non-Executive Non-Independent Director effective September 1, 2026, all subject to shareholder approval at the upcoming AGM.

The board of Sumitomo Chemical India Limited announced the promotion of Dr. Suresh Ramachandran from Deputy Managing Director to Managing Director effective 1 September 2026, subject to shareholder approval via special resolution, following his 28 years of industry experience and prior leadership roles.